Snapdeal to Assist FDA's Investigation Involving Online Sale of Prescription Drugs

by Dr. Trupti Shirole on  May 1, 2015 at 11:28 PM Indian Health News
RSS Email Print This Page Comment
Font : A-A+

The Maharashtra's Food and Drugs Administration (FDA) has lodged a First Information Report (FIR) against e-commerce giant Snapdeal CEO Kunal Bahl for the sale of prescription drugs online. The move came after the FDA raided the premises of Jasper Infotech, which owns Snapdeal, at Goregoan in Mumbai, about two weeks ago. Snapdeal said that it will assist the FDA team's investigation.
Snapdeal to Assist FDA's Investigation Involving Online Sale of Prescription Drugs
Snapdeal to Assist FDA's Investigation Involving Online Sale of Prescription Drugs

A company spokesperson said, "Upon being notified of any such products, we delist the products and take appropriate action against such seller. In this matter, we are assisting FDA team in this investigation, we will continue to do so. Snapdeal acts as an intermediary between the seller and buyer of the products listed on the platform. We educate sellers on consequences of selling inappropriate products, at times sellers end up listing such products. We have already delisted the products and sellers and also stopped payment, in addition to providing all information to the FDA team as required by them."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Antibiotics 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive